A "new era" for Boston Scientific?

February 14, 2013 by MassDevice staff

Boston Scientific officials are bullish that the company will grow sales by the end of the year, ending more than 2 year of sliding revenues.

Boston Scientific

Boston Scientific (NYSE:BSX) expects positive sales growth for the company by the 2nd half of 2013, CFO Jeffrey Capello told MassDevice.com in an interview.

A return to positive sales growth would end nearly 2.5 years of sliding revenues, and the medical device maker still has some rough patches to navigate, he said.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Comments

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp